Company page

Relmada Therapeutics, Inc.

Relmada Therapeutics, Inc. is a public company traded under the ticker RLMD in the American market. The company has a market capitalization of approximately $543.3 million. Relmada focuses on developing innovative therapies for the treatment of chronic pain and related conditions.